ALFA Filings
Every announcement, straight from the exchange
Every Neochem Bio Solutions earnings call announcement on NSE and BSE, newest first, each with its own page.
Time
4 announcements with these filters
Neochem Bio Solutions reported FY26 revenue of ₹110.7 Cr (+32% YoY) and PAT of ₹12.0 Cr (+62% YoY), driven by specialty chemical demand and segment diversification into home and personal care.
Neochem Bio Solutions delivered strong FY26 results with 32% revenue growth and 53% EBITDA growth, driven by a shift to own-brand performance chemicals and expansion into HPC and paints.
Neochem Bio Solutions delivered a strong FY26 with 32% revenue growth and 53% EBITDA expansion, driven by a strategic pivot from white-label manufacturing to its own higher-margin specialty brand.
Neochem Bio Solutions Limited reported FY26 Total Income of ₹113.4cr, reflecting 32% YoY growth. Strategy focuses on diversifying from textile into HPC and industrial specialty chemicals.